WASHINGTON — Nine drugmakers on Friday are set to unveil deals with the Trump administration to lower the prices of some of their drugs, marking the administration’s largest such deal to date.
The deals are the latest in a series of agreements with drugmakers that are aimed at lowering prices to levels paid by peer nations. The new agreements share many characteristics with the previous ones, senior administration officials told reporters Friday.
STAT Pharma: The science and business of new drug development
Leave a Reply